Literature DB >> 9208645

[A model of osteoporosis induced by retinoic acid in male Wistar rats].

B Wu1, B Xu, T Y Huang, J R Wang.   

Abstract

An animal model of osteoporosis induced by retinoic acid was successfully established in 3-month-old male Wistar rats. The animals were given the drug 70 mg.kg-1.d-1 for 14 d intragastrically and sacrificed on day 29. The proximal tibia and middle tibia of the rats were processed undecalcifiedly for quantitative bone histomorphometry. Compared with the control rats, the cancellous and compact bone volume of the model rats were reduced markedly. The bone tissue microstructure showed some obvious pathological changes that the trabecular number were decreased, the separation of trabecular and medulla ossium cavity became large, the thickness of trabecular and cortex of bone were decreased. The mechanism of bone loss in the model rats was that the osteoclast was activated by retinoic acid which promoted bone resorption. Other changes in the model rats were also observed such as: the body weight, and the weights of seminal vesicle and prostate were decreased, the adrenal glands and spleen showed hyperplasia and hypertrophy. No change of the blood concentration of calcium, phosphorus, alkaline phosphatase, alanine transaminase, estradiol and testosterone in the model rats was observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9208645

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  2 in total

1.  Core level regulatory network of osteoblast as molecular mechanism for osteoporosis and treatment.

Authors:  Ruoshi Yuan; Shengfei Ma; Xiaomei Zhu; Jun Li; Yuhong Liang; Tao Liu; Yanxia Zhu; Bingbing Zhang; Shuang Tan; Huajie Guo; Shuguang Guan; Ping Ao; Guangqian Zhou
Journal:  Oncotarget       Date:  2016-01-26

2.  Retinoic acid exacerbates chlorpyrifos action in ensuing adipogenic differentiation of C3H10T½ cells in a GSK3β dependent pathway.

Authors:  Harkirat Singh Sandhu; A J S Bhanwer; Sanjeev Puri
Journal:  PLoS One       Date:  2017-03-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.